Annals of Surgical Treatment and Research

The Korean Surgical Society (대한외과학회)
권호 표지

Is Mammotome Excision Feasible for Benign Breast Mass Bigger than 3 cm in Greatest Dimension?

3 cm 이상의 양성 유방종괴에 대해서도 맘모톰 절제술이 가능한가?

Park, Hai-Lin;Kwak, Jin-Young;Jung, Hae-Kyong;Lee, Seung-Hee;Shim, Jeong-Yun;Kim, Ji-Young;Lee, Kyung-Sik
박해린;곽진영;정혜경;이승희;심정연;김지영;이경식

  • Published : 20060000
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this study was to evaluate that a surgeon can safely remove all sonographic evidence of masses in the breast grater than 3.0 cm in greatest dimension using the 8 g hand held Mammotome (MT). Methods: From Jan. 2003 to Mar. 2005, a total of 1,368 US-guided MT excision were performed in 1,112 patients at Kangnam Cha hospital. Of these 1,368 lesions 28 lesions with BI-RADS category 3 features by ultrasonography were included in this study. Ultrasonographic follow-up were performed on 3∼6 months later to assess residual tissue and scarring. Results: Mean patient age was 32.0 years (range 20${\sim}$55 years). The average size of lesion was 3.5 cm (SD+-0.43 cm). All of the lesions were palpable and all of the specimens were benign. Most common pathologic features were fibroadenoma (75.0%) and breast abscess (14.3%). Mean time required to perform mammotome procedures was 12.2${\pm}$8.2 minutes and mean number of cores removed were 35.1${\pm}$30.2 pieces. No bleeding or infections occurred postoperatively and most complications were mild and anticipated. Conclusion: This study demonstrates that percutaneous removal of big breast benign mass above 3 cm in diameter using The MT system is feasible, effective and safe method for the therapeutic management with minimal morbidity without any additional procedures. (J Korean Surg Soc 2006;70:25-29)

Keywords

References

  1. Alle KM, Moss J, Venegas RJ, Khalkhali I, Klein SR. Conservative management of fibroadenoma of the breast. Br J Surg 1996;83:992-3 https://doi.org/10.1002/bjs.1800830735
  2. Yelland A, Graham MD, Trott PA. Diagnosing breast carcinoma in young women. BMJ 1991;302:618-20 https://doi.org/10.1136/bmj.302.6777.618
  3. Yelland A, Cazet JC, Coombes RC. Conservative management of fibroadenoma of the breast [letter]. Br J Surg 1996;83:1653
  4. Fornage BD, Faroux MJ, Simatos A. Breast masses. US-guided fine-needle aspiration biopsy. Radiology 1987;162:409-14 https://doi.org/10.1148/radiology.162.2.3541029
  5. Sneign N, Fornage BD, Saleh G. Ultrasound guided fine-needle aspiration of non-palpable breast lesion; cytology and histologic findings. Am J Clin Pathol 1994;102:98-101 https://doi.org/10.1093/ajcp/102.1.98
  6. Bear HD. Image guided breast biopsy-how, when and by whom- [editorial]. J Surg Oncol 1998;67:1-5 https://doi.org/10.1002/(SICI)1096-9098(199801)67:1<1::AID-JSO1>3.0.CO;2-F
  7. Parker SH, Klaus AJ, McWey PJ, Schilling KJ, Cupples TE, Duchesne N, et al. Sonographically guided directional vacuum assisted breast biopsy using a hand held device. Am J Roentgenol 2001;177:405-8 https://doi.org/10.2214/ajr.177.2.1770405
  8. Brenner RJ. Lesions entirely removed during stereotactic biopsy. Preoperative localization on the basis of mammographic landmarks and feasibility of freehand technique: initial experience. Radiology 2000;214:585-90 https://doi.org/10.1148/radiology.214.2.r00ja18585
  9. Baez E, Huber A, Vetter M, Hackeroer BJ. Minimal invasive complete excion of benign breast tumors using a threedimensional US-guided Mammotome Vacuum device. Ultrasound Obstet Gynecol 2003;21:267-72 https://doi.org/10.1002/uog.74
  10. Fine RE, Israel PZ, Walker LC, Corgan KR, Greenwald LV, Berenson JE, et al. A prospective study of the removal rate of imaged breast lesions by an 11-gauge vacuum assisted biopsy probe system. Am J Surg 2001;182:335-400 https://doi.org/10.1016/S0002-9610(01)00723-1
  11. Sickles EA. Probably benign breast lesions: when should follow- up be recommended and what is the optimal follow-up protocol- Radiology 1999;213:11-4 https://doi.org/10.1148/radiology.213.1.r99oc4611
  12. Rubin E. Six month follow-up: an alternative view. Radiology 1999;213:15-8 https://doi.org/10.1148/radiology.213.1.r99oc4715
  13. Brenner RJ, Sickles EA. Surveillance mammography and stereotactic core biopsy for probably benign lesions: a cost comparison analysis. Acad Radiol 1997;4:419-25 https://doi.org/10.1016/S1076-6332(97)80048-7
  14. Jackman RJ, Marzoni FA, Nowels KW. Percutaneous removal of benign mamographic lesions: comparison of automated large-core and directional vacuum assisted stereotactic biopsy techniques. AJR 1998;171:1325-30 https://doi.org/10.2214/ajr.171.5.9798873
  15. Liberman L, Dershaw DD, Rosen PP, Morris EA. Percutaneous removal of malignant mammographic lesions at sterotactic vacuum assisted biopsy. Radiology 1998;206:711-5 https://doi.org/10.1148/radiology.206.3.9494489
  16. Jackman RJ, Nowels KW, Rodriguez-soto J. Stereotactic automated large core needle biopsy of non palpable breast lesions: false negative and histologic underestimation rates after long term follow-up. Radiology 1999;210:799-805 https://doi.org/10.1148/radiology.210.3.r99mr19799
  17. Parker SH. Sonographically guided directional vacuum-assisted breast biopsy using a handheld device. Am J Surg 2001; 177:405-8 https://doi.org/10.1016/S0002-9610(99)00069-0
  18. Vargas HI, Agbunag RV, Khalkhali I. State of art of minimally invasive breast biopsy: principles and practice. Breast Cancer 2000;7:370-9 https://doi.org/10.1007/BF02966407
  19. Perez-Fuentez JA, Longobardi IR, Acosta VF. Sonographically guided directional vacuum assisted breast biopsy: preliminary experience in Venezuaela. AJR 2001;177:1459-63 https://doi.org/10.2214/ajr.177.6.1771459
  20. March DE, Coughlin BF, Barham RB. Breast masses: removal of all US evidence during biopsy by using a handheld vacuum assisted device-initial experience. Radiology 2003;227:549-55 https://doi.org/10.1148/radiol.2272020476
  21. Park HL, Kwak JY, Lee SH, Kim JY, Kim KI, Kim WW, et al. Excision of benign breast disease by US guided vacuum assisted biopsy device (mammotom). J Korean Surg Soc 2005; 68:96-101